We’ve just launched a new portal to help you explore stocks, crypto, ETFs, and more data

AZN

LSE
11,724 GBP
16
0.14%
Last update Feb 17, 4:29 PM GMT
Market closed
Day range
11,644
11,734
Previous close
11,708
Open
11,682
Access this stock data via API
Subscribe
AstraZeneca PLC
11,724.00
16
0.14%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 54.1B 45.8B 44.4B 37.4B
Cost of revenue 10.2B 8.3B 12.4B 12.4B
Gross profit 43.9B 37.5B 32.0B 25.0B
Operating expense
Research & development 13.6B 10.9B 9.8B 9.7B
Selling general and admin 20.5B 18.2B 18.0B 15.6B
Other operating expenses 164M 200M 308M
Operating income 10.0B 8.7B 4.5B -139M
Non operating interest income
Income 458M 301M 81M 43M
Expense 1.7B 1.6B 1.3B 1.3B
Other income expense
Pretax income 8.7B 6.9B 2.5B -265M
Tax provision 1.7B 938M -792M -380M
Net income 7.0B 6.0B 3.3B 115M
Basic EPS 4.5 3.8 2.1 0.1
Diluted EPS 4.5 3.8 2.1 0.1
Basic average shares 2.0B 1.9B 1.9B 1.8B
Diluted average shares 2.0B 1.9B 1.9B 1.8B
EBITDA 17.1B 13.9B 9.8B 3.9B
Net income from continuing op. 8.7B 6.9B 2.5B -265M
Minority interests -6M -6M -5M -3M
Preferred stock dividends 0 0 0 0